TrialBreast cancer research : BCR2013

A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer.

Davide Serrano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.